亚洲AV成人片无码网站玉蒲团,男人10处有痣是富贵痣,AV亚洲欧洲日产国码无码苍井空,日韩午夜欧美精品一二三四区

深圳遠揚化學技術有限公司
中級會員 | 第9年

15012456311

當前位置:深圳遠揚化學技術有限公司>>藥物雜質對照品>>雜質>> 利格列汀雜質 利拉利汀雜質

利格列汀雜質 利拉利汀雜質

參   考   價: 100

訂  貨  量: ≥1 

具體成交價以合同協議為準

產品型號

品       牌其他品牌

廠商性質生產商

所  在  地深圳市

更新時間:2022-03-17 15:16:26瀏覽次數:1455次

聯系我時,請告知來自 化工儀器網
利格列汀雜質 利拉利汀雜質
Linagliptin Impurity
提供NMR,HPLC,MS圖譜及COA證書,新藥申報可用
全部雜質現貨供應,*,并可接受定制。
25mg/50mg/100mg等多種規格可選。

利格列汀雜質 利拉利汀雜質??   產品介紹:
規格:10mg/25mg/50mg/100mg等多種規格可選。
用途:實驗研發,藥品申報檢測,不得用于臨床醫學診斷。
隨貨提供:所有雜質對照品均隨貨提供HPLC,NMR,MS圖譜及CoA證書。

 

國產進口品牌皆有銷售,產品庫時常更新,部分雜質長期備有庫存,可當天發貨,另外,我司有專業研發團隊,可提供雜質定制服務,以zui大可能的滿足您對雜質對照品的選購需求。

 

利格列汀雜質 利拉利汀雜質??   雜質列表:

Linagliptin(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 1 7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 22-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide
Linagliptin Impurity 3(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 4(R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 5N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide
Linagliptin Impurity 6(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid
Linagliptin Impurity 78-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)
Linagliptin Impurity 8(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
Linagliptin Impurity 98-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 10(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 11(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 128-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 13(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 14(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 15(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 16(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
Linagliptin Impurity 17(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 187-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 19N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 20(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 21(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
Linagliptin Impurity 22(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 23(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 24(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Linagliptin Impurity 25(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Impurity 26(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide

 

??       我司主營醫藥標準品及雜質對照品,以下雜質備有庫存,可當天發貨,*: 依魯替尼雜質,奧貝膽酸雜質,依美斯汀雜質,卡格列凈雜質,利格列汀雜質,西格列汀雜質,埃索美拉唑雜質,LCZ696雜質,恩雜魯胺雜質,艾曲波帕雜質,非布司他雜質,托匹司他雜質,樂伐替尼雜質,奧拉帕尼雜質,阿維巴坦雜質,奧美拉唑雜質,普卡必利雜質,西他沙星雜質,泊沙康唑雜質,替格瑞洛雜質,托法替尼雜質,決奈達隆雜質,阿奇霉素雜質等。 

 

 

??    美國劍橋CIL標準品部分產品列表:

DLM-277-PK                HEXANOIC ACID (D11, 98%)

CLM-9146-0.01            5-ALPHA-DIHYDROTESTOSTERONE 97% CHEMICAL PURITY (2,3,4-13C3,99%)

EDF-4143-1                 CALIBRATION CURVE, CDC1 DIOXIN, FURAN, & PCB IN TISSUE IN NONANE

JR-D45-25                   1,2,4,6,7,9-HEXACDD UNLABELED ~25 NG/ML IN NONANE

CGM-1000-CN-20-S      BIOEXPRESS CELL GROWTH MEDIA (U-13C, 19%; U-15N, 98%) (10X CONCENTRATE)

DLM-2084-PK               L-DOPA (RING-D3, 98%)

H-922                         ALPHA-HYDROXYMIDAZOLAM UNLABELED 1.0 MG/ML IN METHANOL

CRLM-4396-0               CHROMIUM-54 OXIDE (54Cr)

CLM-1896-PK               INDOLE-3-ACETIC ACID (PHENYL-13C6, 99%)

H-049                         HYDROMORPHONE (D6, 98%) 100 UG/ML IN METHANOL

EC-5000                      WHO COPLANAR & MONO-ORTHO PCB + PCB-170 & PCB-180 UNLABELED 2 UG/ML IN ISOOCTANE

CDLM-7754-PK             SUCCINIC ACID (13C4, 99%; 2,2,3,3-D4, 98%)

DLM-143-5X1               1,1,1,3,3,3-HEXAFLUOROISOPROPANOL-D2 (D, 98%)

PCB-170-C                  2,2',3,3',4,4',5-HEPTACB UNLABELED

CLM-3876-PK               SODIUM OCTANOATE (1,2,3,4-13C4, 99%)

CNLM-6696-PK             CELL FREE AMINO ACID MIX (20 AA) (U-13C, 97-99%+; U-15N, 97-99%)

ES-5038-1-10X-1         CLP VOLATILES NON-KETONE DMC 10X STOCK SOLUTION 1000 UG/ML IN METHANOL-OD

EC-1436-1.2                2,2',3,4,4',5'-HEXACB (PCB-138) (13C12, 99%) 40+/-2 UG/ML IN NONANE

CLM-2093-MPT-PK        ALPHA-KETOISOCAPROIC ACID, SODIUM SALT (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED

DLM-10-PK                  DIMETHYL SULFOXIDE-D6 (D, 99.9%)

EDF-5429-CS8H           TWO COLUMN DIOXIN & FURAN CALIBRATION SOLUTION CS8H (UNLABELED/13C12, 99%)

CLM-156-MPT-PK          SODIUM ACETATE (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED

DLM-6196-1.2              METHYLPHOSPHONIC ACID (METHYL-D3, 98%) 100 UG/ML IN METHANOL

CLM-2456-PK               D-XYLOSE (1,2-13C2, 99%)

PCB-166-C                  2,3,4,4',5,6-HEXACB UNLABELED

CDLM-7582-SL-1          HIS-UBIQUITIN DC (13C, 98%; D, 98%) *DISCONTINUED*

ULM-9091-1.2              TRIPHENYL PHOSPHATE UNLABELED 1 MG/ML IN ACETONITRILE

DLM-4721-0.5              L-CYSTEINE-N-FMOC, S-TRITYL (3,3-D2, 98%)

 

更多關于   ??    的產品信息,請我司獲取詳情~

 

會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

X
該信息已收藏!
標簽:
保存成功

(空格分隔,最多3個,單個標簽最多10個字符)

常用:

提示

X
您的留言已提交成功!我們將在第一時間回復您~
撥打電話
在線留言